Vaccination against cocaine using a modifiable dendrimer nanoparticle platform
| Autor: | Sylvia Daunert, Ralf Landgraf, Emre Dikici, Pirouz Daftarian, Jeffrey A. Lowell, Vance Lemmon, Pratibha M. Joshi, Sari Izenwasser |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Dendrimers
Intrinsic activity medicine.medical_treatment 030231 tropical medicine Active immunization 03 medical and health sciences Mice 0302 clinical medicine Immune system Antigen Adjuvants Immunologic Cocaine medicine Animals Humans 030212 general & internal medicine Vaccines General Veterinary General Immunology and Microbiology biology business.industry Vaccination Public Health Environmental and Occupational Health Conditioned place preference Rats Infectious Diseases Immunology biology.protein Molecular Medicine Nanoparticles Antibody business Adjuvant |
| Zdroj: | Vaccine. 38(50) |
| ISSN: | 1873-2518 |
| Popis: | Pharmacological therapies for the treatment of cocaine addiction have had disappointing efficacy, and the lack of recent developments in the clinical care of cocaine-addicted patients indicates a need for novel treatment strategies. Recent studies have shown that vaccination against cocaine to elicit production of antibodies that reduce concentrations of free drug in the blood is a promising method to protect against the effects of cocaine and reduce rates of relapse. However, the poorly immunogenic nature of cocaine remains a major hurdle to active immunization. Therefore, we hypothesized that strategies to increase targeted exposure of cocaine to the immune system may produce a more effective vaccine. To specifically direct an immune response against cocaine, in the present study we have conjugated a cocaine analog to a dendrimer-based nanoparticle carrier with MHC II-binding moieties that previously has been shown to activate antigen-presenting cells necessary for antibody production. This strategy produced a rapid, prolonged, and high affinity anti-cocaine antibody response without the need for an adjuvant. Surprisingly, additional evaluation using multiple adjuvant formulations in two strains of inbred mice found adjuvants were either functionally redundant or deleterious in the vaccination against cocaine using this platform. The use of conditioned place preference in rats after administration of this vaccine provided proof of concept for the ability of this vaccine to diminish cocaine reward. Together these data demonstrate the intrinsic efficacy of an immune-targeting dendrimer-based cocaine vaccine, with a vast potential for design of future vaccines against other poorly immunogenic antigens by substitution of the conjugated cargo. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect